References
- Baluk, P., Thurston, G., Murphy, T.J., Bunnett, N.W. and McDonald, D.M. (1999 ) “Neurogenic plasma leakage in mouse airways”, British Journal of Pharmacology 126, 522–528.
- Bertrand, C. and Geppetti, P. (1996 ) “Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergic airway disease”, Trends in Pharmacological Sciences 17, 225–259.
- Bertrand, C., Nadel, J.A., Yamawaki, I. and Geppetti, P. (1993 ) “Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea”, Journal of Immunology 151, 4902–4907.
- Bhoola, K.D. (1996 ) “Translocation of the neutrophil kinin moiety and changes in the regulation of kinin receptors in inflammation”, Immunopharmacology 33, 247–256.
- Boichot, E., Biyah, K., Germain, N., Emonds-Alt, X., Lagente, V. and Advenier, C. (1996 ) “Involvement of tachykinin NK1 and NK2 receptors in substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea- pigs”, European Respiratory Journal 9, 1445–1450.
- Bormann, H. and Melzig, M.F. (2000 ) “Inhibition of metallopepti- dases by flavonoids and related compounds”, Pharmazie 55, 129–132.
- Borson, D.B. (1991) “Roles of neutral endopeptidase in airways”, American Journal of Physiology 260, L212–L225.
- Bowden, J.J., Garland, A.M. and Baluk, P. (1994 ) “Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation”, Proceedings of the National Academy of Sciences of the USA 91, 8964–8968.
- Cyrino, L.A.R., Cardoso, R.C.F., Hackl, L.P.N. and Nicolau, N. (2002 ) “Effects of quercetin on plasma extravasation in rat CNS and dura mater by ACE and NEP inhibition”, Phytotherapy Research 16, 545–549.
- Dahanukar, S.A., Kulkarni, R.A. and Rege, N.N. (2000 ) “Pharmacology of medicinal plants and natural products”, Indian Journal of Pharmacology 32, S81–S118.
- Ebersberger, A., Averbeck, B., Messlinger, K. and Reeh, P.W. (1999) “Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro”, Neuroscience 89, 901–907.
- Emanueli, C., Grady, E.F., Madeddu, P., Figini, M., Bunnett, N.W., Parisi, D., Regoli, D. and Geppetti, P. (1998 ) “Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P”, Hypertension 31, 1299–1304.
- Formica, J.V. and Regelson, W. (1995 ) “Review of the biology of quercetin and related bioflavonoids”, Food Chemistry and Toxicology 33, 1061–1080.
- Hackl, L.P.N., Cuttle, G., Sanches Dovichi, S., Lima-Landman, M.T. and Nicolau, M. (2002 ) “Inhibition of angiotensin-converting enzyme by quercetin alters the vascular response to bradykinin and angiotensin”, Pharmacology 65, 182–186.
- Hollman, P.C.H. and Katan, M.B. (1997 ) “Absorption, metabolism and health effects of dietary flavonoids in man”, Biomedicine and Pharmacotherapy 51, 305–310.
- Hollman, P.C.H. and Arts, I.C.W. (2000 ) “Flavonols, flavones and flavanols—nature, occurrence and dietary burden”, Journal of the Science of Food and Agriculture 80, 1081–1093.
- Korkina, L.G. and Afanas’ev, I.B. (1997) “Antioxidant and chelating properties of flavonoids”, In: Sies, H., ed, Advances in Pharmacology (Academic Press, San Diego: California ), pp 151–160.
- Lin, J.Y., Chen, T.S. and Chen, C.S. (1994 ) “Flavonoids as nonpeptide angiotensin-converting enzyme inhibitors for hypertension treatment”, Chemical Abstracts 121, 126.
- Lindell, E., Svensjo, M.E., Malm, L. and Petersson, G. (1995 ) “Tachykinin-induced nasal fluid secretion and plasma exudation in the rat: effects of peptidase inhibition”, Neuropeptides 28, 309–315.
- Lu, B., Figini, M., Emanueli, C., Gepetti, P., Grady, E.F., Gerard, N.P., Ansell, J., Payan, D.G., Gerard, C. and Bunnett, N. (1997 ) “The control of microvascular permeability and blood pressure by neutral endopeptidase”, Nature Medicine 3, 904–907.
- Maggi, C.A. (1991 ) “The pharmacology of the efferent function of sensory nerves”, Journal of Autonomic Pharmacology 11, 173–208.
- Maggi, C.A. (1996 ) “Tachykinins in the autonomic nervous system”, Pharmacological Research 33, 161–170.
- Maggi, C.A., Santicioli, P., Abelli, L., Parlani, M., Capasso, M., Conte, B., Giuliani, S. and Meli, A. (1987 ) “Regional differences in effects of capsaicin and tachykinins on motor activity and vascular permeability of the rat lower urinary tract”, Naunyn-Schmiedeberg’s Archives of Pharmacology 335, 636–645.
- Marceau, F. and Bachvarov, D.R. (1998 ) “Kinin receptors”, Clinical Reviews in Allergic Immunology 16, 385–401.
- Middleton, E., Jr. and Kandaswami, C. (1993 ) “The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer ”, In: Harbone, J.B., ed, The Flavonoids:Advances in Research Since 1986 (Chapman and Hall, London, UK ), pp 619–652.
- Nicolau, M., Sirois, M.G., Bui, M., Plante, G.E., Sirois, P. and Regoli, D. (1993 ) “Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists”, Canadian Journal of Physiology and Pharmacology 71, 217–221.
- Piedimonte, G. (1995 ) “Tachykinin peptides, receptors and peptidases in airway disease”, Experimental Lung Research 21, 809–834.
- Rice-Evans, C., Miller, N.J. and Paganga, G. (1997 ) “Antioxidant properties of phenolic compounds”, Trends in Plant Sciences 2, 152–159.
- Santos, R., Krieger, E.M. and Greene, L.J. (1985 ) “An improved fluorimetric assay of rat serum and plasma converting enzyme”, Hypertension 7, 244–252.
- Saria, A., Lundberg, J.M., Skofitsch, G. and Lembeck, F. (1983 ) “Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge”, Naunyn-Schmiedeberg’s Archives of Pharmacology 324, 212–218.
- Sato, M., Miyazaki, T., Kambe, F., Maeda, K. and Seo, H. (1997 ) “Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-α in cultured human synovial cells”, Journal of Rheumatology 24, 1680–1684.
- Sestili, P., Guidarelli, A., Dadra, M. and Cantoni, O. (1998 ) “Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism”, Free Radicals in Biology and Medicine 25, 196–200.
- Shen, S.-C., Lee, W.-R., Lin, H.-Y., Huang, H.-C., Ko, C.-H., Yang, L.-L. and Chen, Y.-C. (2002 ) “In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production”, European Journal of Pharmacology 446, 18 27–194.
- Takagi, T., Takekoshi, S., Okabe, T., Nagata, H., Honma, T. and Watanabe, K. (1998 ) “Quercetin, a flavonol, promotes disassembly of microtubules in prostate cancer cells: possible mechanisms of its antitumor activity”, Acta Histochemistry Cytochemistry 31, 435–445.
- Turner, A.J. and Barnes, K. (1995 ) “Distribution and roles of endopeptidase 24.11”, Methods in Neurosciences 23, 344–359.
- Wagner, H., Elbl, G., Lotter, H. and Guinea, M. (1991 ) “Evaluation of natural products as inhibitors of angiotensin I-converting enzyme (ACE)”, Pharmaceutical and Pharmacological Letters 1, 15–18.
- Wille, P.R., Ribeiro-do-Valle, R.M., Simoes, C.M.O., Gabilan, N.H. and Nicolau, M. (2001) “Effect of quercetin on tachykinin- induced plasma extravasation in rat urinary bladder”, Phytotherapy Research 15, 444–446.